ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1781

Cytokine Dependence of Enthesis-resident Lymphocytes in Murine Spondyloarthritis

Mederbek Matmusaev 1, Emma Haley1, Imtiyaz Hossain 1 and Joerg Ermann 1, 1Brigham and Women's Hospital, Boston

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: IL-23 and IL-1, Mouse model, Spondylarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: 4M095: Spondyloarthritis Including Psoriatic Arthritis – Basic Science (1776–1781)

Session Type: ACR Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Enthesis-resident CD4-CD8- double-negative (DN) T cells have been implicated in the pathogenesis of spondyloarthritis. Overexpression of IL-23 in adult mice activates these cells to produce IL-17A and other pathogenic cytokines leading to spondyloarthritis-like disease. Many innate lymphocytes require IL-1 for IL-23-induced production of IL-17A in vitro. We therefore investigated the role of IL-1 receptor signals on CD4-CD8- DN T cell homeostasis and induction of murine spondyloarthritis.

Methods: Lymphocytes were isolated from the spleen and Achilles enthesis of wildtype, Il23r-/-, Il1r1-/- and Il23r-gfp reporter mice (C57BL/6 background) and analyzed in vitro. Disease was induced by hydrodynamic injection of IL-23 minicircles (System Biosciences) in B10.RIII mice. To block IL-1 signals, animals were injected ip. with a cocktail of three monoclonal antibodies against IL-1α, IL-1β and IL-1R1. Animals were monitored every other day for arthritis development. Animals were euthanized two weeks after disease induction for tissue harvest and analysis.

Results: Enthesial CD4-CD8- DN T cells comprise γδ T cells and DN αβ T cells. Both γδ T cells and DN αβ T cells secreted IL-17A upon in vitro stimulation with IL-23 + IL-1β but not IL-23 alone. Cell frequencies were not substantially different in Il23r-/- or Il1r1-/- mice compared with wildtype mice. Disease induction in Il1r1-/- mice could not be tested as C57BL/6 wildtype mice do not develop arthritis upon IL-23 minicircle injection. Antibody blockade of IL-1 signals in susceptible B10.RIII mice had no impact on disease incidence but ameliorated arthritis severity.

Conclusion: IL-23 and IL-1 receptor signals control the function but not the development of enthesial γδ T cells and DN αβ T cells. Antibody-mediated blockade of IL-1 in susceptible B10.RIII mice reduced arthritis severity but not disease incidence suggesting that mediators other than IL-1 may provide a second signal for IL-23-induced IL-17A production in vivo. The lack of arthritis development in C57BL/6 mice injected with IL-23 minicircles diminishes the utility of this model for studies of spondyloarthritis pathogenesis. 


Disclosure: M. Matmusaev, None; E. Haley, None; I. Hossain, None; J. Ermann, Boehringer Ingelheim, 2, Eli Lilly, 5, Novartis, 5, Pfizer, 2, UCB, 5.

To cite this abstract in AMA style:

Matmusaev M, Haley E, Hossain I, Ermann J. Cytokine Dependence of Enthesis-resident Lymphocytes in Murine Spondyloarthritis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/cytokine-dependence-of-enthesis-resident-lymphocytes-in-murine-spondyloarthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cytokine-dependence-of-enthesis-resident-lymphocytes-in-murine-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology